When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OTSKY - Otsuka doublet therapy successful in late-stage blood cancer study
Otsuka Holdings Co. Ltd. ADR
Otsuka (OTCPK:OTSKY) units Astex Pharmaceuticals and Otsuka Pharmaceutical Co. announce positive results from a Phase 3 clinical trial, ASCERTAIN, evaluating the oral fixed-dose combination of cedazuridine and Dacogen (decitabine) (known as ASTX727) in patients with myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML).
More news on: Otsuka Holdings Co., Ltd., Otsuka Holdings Co., Ltd., OTSUKA CORP, Healthcare stocks news,